Ypsomed Holding AG

0QLQ · LSE

432.80GBP-4.10 (-0.94%)

Price History

Full chart

Market Stats

Previous Close436.90

Open436.20

Day Range430.40 – 436.20

52-Week Range263.48 – 417.00

Volume306

Market Cap3.53B

P/E (TTM)1.98

Forward P/E0.00

EPS1.83

Dividend Yield0.00%

Beta0.77

50-Day Avg327.99

200-Day Avg281.05

About

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Company Details

CEOMr. Simon Michel
Employees2.02K
HeadquartersBrunnmattstrasse 6, Burgdorf, Switzerland, 3401, UK
Websitehttps://www.ypsomed.com

Leadership

Mr. Simon MichelCEO, Member of Executive Board & Member of the Board · b. 1977
Mr. Samuel KunzliChief Financial Officer & Member of Executive Board · b. 1984
Ms. Ulrike BauerChief Business Officer & Member of Executive Board · b. 1969
Mr. Frank MengisCOO, Deputy CEO Member of Executive Board · b. 1964
Mr. Michael ZauggChief Corporate Officer & Member of Executive Board · b. 1972
Dr. Nicolas MeyerChief Legal Officer & Secretary and Member of Executive Board · b. 1971
Sam GhezelbashHead of Investor Relations & M&A

Financials

Income Statement

Currency: GBP	2002-03-31	2003-03-31	2004-03-31	2005-03-31	2006-03-31	2007-03-31	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31

Currency: GBP	2002-03-31	2003-03-31	2004-03-31	2005-03-31	2006-03-31	2007-03-31	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Total Revenue	100.61M	137.19M	185.37M	241.82M	310.59M	277.45M	287.47M	272.58M	254.01M	242.46M	248.59M	244.56M	276.26M	306.63M	336.92M	389.56M	466.12M	453.76M	394.26M	403.66M	464.84M	497.46M	548.46M	748.87M	730.98M
Growth (%)	-	+36.35%	+35.12%	+30.46%	+28.44%	-10.67%	+3.61%	-5.18%	-6.81%	-4.55%	+2.53%	-1.62%	+12.96%	+11.00%	+9.88%	+15.62%	+19.65%	-2.65%	-13.11%	+2.38%	+15.16%	+7.02%	+10.25%	+36.54%	-2.39%
Cost of Revenue	74.95M	94.92M	113.64M	144.94M	191.38M	213.21M	197.27M	188.58M	187.57M	175.74M	192.22M	187.49M	205.73M	220.78M	233.74M	264.08M	326.29M	297.35M	303.29M	308.83M	351.02M	356.87M	359.40M	456.80M	416.38M
Gross Profit	25.66M	42.27M	71.72M	96.89M	119.21M	64.24M	90.20M	84.00M	66.45M	66.72M	56.37M	57.08M	70.53M	85.85M	103.19M	125.48M	139.83M	156.41M	90.97M	94.83M	113.82M	140.59M	189.05M	292.07M	314.61M
Gross Margin	25.50%	30.81%	38.69%	40.07%	38.38%	23.15%	31.38%	30.82%	26.16%	27.52%	22.68%	23.34%	25.53%	28.00%	30.63%	32.21%	30.00%	34.47%	23.07%	23.49%	24.49%	28.26%	34.47%	39.00%	43.04%
Operating Expense	18.97M	28.07M	54.49M	75.63M	56.87M	61.90M	59.22M	53.58M	53.00M	58.11M	51.23M	52.23M	54.98M	58.91M	58.93M	70.20M	78.96M	83.25M	89.16M	85.56M	85.24M	80.00M	102.83M	179.22M	129.93M
Operating Income	6.69M	14.20M	17.23M	21.26M	62.34M	2.34M	30.98M	30.43M	13.45M	8.61M	5.14M	4.85M	15.54M	26.95M	44.25M	55.28M	60.87M	73.16M	1.82M	9.27M	28.58M	60.59M	86.22M	112.85M	184.68M
Operating Margin	6.65%	10.35%	9.30%	8.79%	20.07%	0.84%	10.78%	11.16%	5.29%	3.55%	2.07%	1.98%	5.63%	8.79%	13.13%	14.19%	13.06%	16.12%	0.46%	2.30%	6.15%	12.18%	15.72%	15.07%	25.26%
EBITDA	18.66M	27.65M	47.31M	43.07M	92.19M	27.40M	55.20M	53.46M	39.91M	33.91M	36.98M	29.32M	35.32M	47.41M	64.64M	86.56M	97.08M	115.59M	61.63M	63.86M	95.67M	137.51M	161.56M	190.90M	266.89M
EBITDA Margin	18.55%	20.15%	25.52%	17.81%	29.68%	9.88%	19.20%	19.61%	15.71%	13.98%	14.87%	11.99%	12.79%	15.46%	19.19%	22.22%	20.83%	25.47%	15.63%	15.82%	20.58%	27.64%	29.46%	25.49%	36.51%
Net Income	5.78M	12.06M	11.59M	39.20M	55.65M	2.74M	26.58M	26.17M	9.43M	5.21M	8.50M	1.65M	13.61M	19.39M	35.81M	46.25M	52.06M	60.14M	11.73M	5.81M	23.11M	51.27M	78.37M	87.50M	221.93M
Net Income Margin	5.74%	8.79%	6.25%	16.21%	17.92%	0.99%	9.25%	9.60%	3.71%	2.15%	3.42%	0.67%	4.93%	6.33%	10.63%	11.87%	11.17%	13.25%	2.98%	1.44%	4.97%	10.31%	14.29%	11.68%	30.36%
R&D	795.00K	4.56M	6.40M	40.58M	17.21M	21.91M	43.23M	10.46M	7.32M	9.25M	-	26.98M	27.71M	33.46M	32.26M	38.66M	40.55M	56.84M	42.00M	16.79M	21.95M	28.95M	30.48M	33.55M	40.02M
R&D as % of Total Revenue	0.79%	3.32%	3.45%	16.78%	5.54%	7.90%	15.04%	3.84%	2.88%	3.81%	-	11.03%	10.03%	10.91%	9.57%	9.93%	8.70%	12.53%	10.65%	4.16%	4.72%	5.82%	5.56%	4.48%	5.48%
Interest Expense	26.00K	47.00K	-	1.60M	1.07M	1.23M	4.05M	6.87M	2.66M	2.60M	785.00K	874.00K	1.04M	845.00K	632.80K	477.55K	656.00K	827.39K	980.00K	2.02M	2.27M	2.31M	5.04M	6.64M	3.59M
Interest Expense % of Total Revenue	0.03%	0.03%	-	0.66%	0.34%	0.44%	1.41%	2.52%	1.05%	1.07%	0.32%	0.36%	0.38%	0.28%	0.19%	0.12%	0.14%	0.18%	0.25%	0.50%	0.49%	0.46%	0.92%	0.89%	0.49%

Balance Sheet

Currency: GBP	2002-03-31	2003-03-31	2004-03-31	2005-03-31	2006-03-31	2007-03-31	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31

Currency: GBP	2002-03-31	2003-03-31	2004-03-31	2005-03-31	2006-03-31	2007-03-31	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Total Assets	117.12M	142.96M	500.78M	658.48M	665.70M	622.79M	638.23M	632.22M	662.01M	674.63M	327.27M	341.79M	354.53M	361.21M	388.87M	421.80M	500.24M	587.75M	678.24M	717.68M	756.91M	861.88M	1.10B	1.33B	1.35B
Total Liabilities	21.54M	31.28M	488.94M	301.31M	261.69M	232.76M	220.65M	195.19M	124.27M	136.58M	109.27M	124.42M	126.37M	120.57M	121.03M	120.00M	158.70M	208.94M	292.89M	322.30M	364.37M	299.55M	483.66M	650.66M	598.46M
Total Equity	95.58M	111.68M	11.84M	357.17M	404.01M	390.03M	417.58M	437.03M	537.74M	538.06M	218.00M	217.37M	228.16M	240.64M	267.84M	301.80M	341.54M	378.80M	375.17M	395.38M	392.54M	562.33M	617.73M	679.68M	748.13M
Cash	1.93M	3.89M	12.62M	55.98M	65.67M	40.72M	38.29M	8.99M	8.06M	5.02M	9.73M	9.61M	16.16M	16.24M	25.51M	38.88M	32.11M	12.08M	12.17M	18.15M	15.86M	24.48M	74.02M	36.49M	28.56M
Total Debt	-	-	-	-	200.00M	180.00M	-	-	-	-	14.50M	20.00M	20.00M	15.00M	49.00M	37.00M	59.00M	122.00M	193.00M	215.00M	267.00M	157.00M	256.00M	267.00M	260.77M
Net Debt	-1.93M	-3.89M	-12.62M	-55.98M	134.33M	139.28M	-38.29M	-8.99M	-8.06M	-5.02M	4.76M	10.39M	3.84M	-1.24M	23.49M	-1.88M	26.89M	109.92M	180.83M	196.85M	251.14M	132.52M	181.98M	230.50M	232.21M

Cash Flow

Currency: CHF	2002-03-31	2003-03-31	2004-03-31	2005-03-31	2006-03-31	2007-03-31	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31

Currency: CHF	2002-03-31	2003-03-31	2004-03-31	2005-03-31	2006-03-31	2007-03-31	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Operating Cash Flow	6.50M	20.40M	26.54M	94.78M	46.37M	30.96M	70.16M	48.40M	22.48M	29.50M	31.05M	15.17M	41.21M	41.38M	76.69M	75.06M	53.27M	59.86M	49.09M	85.83M	85.71M	129.53M	163.22M	148.20M	306.76M
Investing Cash Flow	-18.47M	-22.48M	-38.75K	66.37M	-9.43M	-19.10M	52.31M	49.59M	-43.74M	-27.46M	-19.78M	-26.29M	-30.06M	-26.23M	-35.98M	-38.05M	-65.82M	-128.39M	-115.83M	-106.91M	-125.70M	-122.02M	-195.07M	-267.27M	-27.49M
Financing Cash Flow	12.86M	4.04M	17.38M	14.96M	-27.28M	-36.90M	20.13M	28.04M	20.49M	-4.91M	-6.42M	10.96M	-4.52M	-14.17M	-31.66M	-23.23M	4.59M	49.09M	68.66M	26.67M	38.13M	1.26M	81.07M	82.25M	-286.45M
Capital Expenditure	18.74M	22.92M	38.01M	72.47M	30.55M	23.40M	53.35M	0	46.38M	26.22M	15.93M	26.41M	18.53M	17.21M	25.15M	27.48M	51.03M	106.80M	76.75M	59.18M	51.59M	98.88M	195.31M	277.15M	295.57M
Free Cash Flow	-12.24M	-2.52M	-11.47M	22.30M	15.82M	7.56M	16.81M	48.40M	-23.90M	3.28M	15.13M	-11.24M	22.68M	24.17M	51.53M	47.58M	2.24M	-46.94M	-27.66M	26.64M	34.11M	30.65M	-32.09M	-128.95M	11.18M
Dividends Paid	-	-	-	-	-	-	-	-	-	-	2.53M	2.52M	2.52M	3.78M	7.58M	12.61M	16.41M	17.64M	6.93M	2.52M	14.67M	8.19M	17.75M	27.30M	30.02M
FCF to OCF	-188.50%	-12.36%	-43.24%	23.53%	34.12%	24.42%	23.96%	100.00%	-106.32%	11.12%	48.72%	-74.12%	55.03%	58.41%	67.20%	63.39%	4.21%	-78.42%	-56.35%	31.04%	39.80%	23.66%	-19.66%	-87.01%	3.65%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	16.73%	-22.44%	11.13%	15.66%	14.70%	26.51%	732.08%	-37.59%	-25.06%	9.46%	42.99%	26.72%	-55.30%	-21.17%	268.43%

Earnings

Report Date	Nov 11, 2026
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	Pre-market

Key Statistics & Ratios

Market Cap3.53B

Enterprise Value5.06B

Trailing P/E1.98

Forward P/E0.00

Price / Sales4.48

Price / Book0.00

EPS1.83

Book Value56.91

Revenue (TTM)730.98M

Gross Profit (TTM)314.61M

EBITDA325.79M

Profit Margin30.36%

Operating Margin26.45%

Return on Equity31.09%

Return on Assets12.36%

Shares Outstanding12.60M

Shares Float3.51M

Beta0.77

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20261×

0.03Jul 3, 2026

20251×

0.01Jul 4, 2025

20241×

0.01Jul 1, 2024

20231×

0.01Jul 3, 2023

20221×

0.00Jul 4, 2022

20211×

0.01Jul 7, 2021

20201×

0.00Jul 8, 2020

20191×

0.01Jul 3, 2019

20181×

0.01Jul 3, 2018

20171×

0.01Jul 4, 2017

20161×

0.01Jul 5, 2016

Stock Splits

Jun 16, 20221955:1949